Tilray Inc (NASDAQ:TLRY)
| 8.00 Delayed Data As of Jul 10 |  +0.59 / +7.96%Today’s Change | 2.43 Today|||52-Week Range 46.67 | -53.30% Year-to-Date |
Latest TLRY News | Press Releases
| Tilray Is Still Trying to Be a Growth Stock. Is It a Brilliant Strategy or a Misguided Move? Jul 09 / MotleyFool.com - Paid Partner Content | Which of These 2 Ultra-Growth Stocks Is Best? Jul 01 / MotleyFool.com - Paid Partner Content |
| Constellation Brands Takes Another Loss on Marijuana Producer Canopy Growth Jul 01 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 7.41 |
| Today’s open | 7.59 |
| Day’s range | 7.43 - 8.09 |
| Volume | 155,891 |
| Average volume (3 months) | 11,958,564 |
| Market cap | $996.4M |
Data as of 4:04pm ET, 07/10/2020
Growth & Valuation
| Earnings growth (last year) | -291.90% |
| Earnings growth (this year) | +25.20% |
| Earnings growth (next 5 years) | +19.45% |
| Revenue growth (last year) | +287.15% |
| P/E ratio | NM |
| Price/Sales | 10.31 |
| Price/Book | 2.88 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RTRXRetrophin Inc | -0.10 | -0.50% |
| ATRAAtara Biotherapeutic... | -0.64 | -4.18% |
| BTAIBioXcel Therapeutics... | +0.28 | +0.54% |
| BCRXBioCryst Pharmaceuti... | -0.10 | -1.72% |
Data as of 4:02pm ET, 07/10/2020
Financials
| Next reporting date | September 1, 2020 |
| EPS forecast (this quarter) | -$0.33 |
| Annual revenue (last year) | $167.0M |
| Annual profit (last year) | -$321.2M |
| Net profit margin | -192.34% |
Profile
Sector Process Industries |
Industry Agricultural Commodities/Milling |
No executives to display |
Corporate headquarters Nanaimo, British Columbia |
Forecasts
